Envafolimab Combined With Endostar and Concurrent Chemoradiotherapy for Locally Advanced Primary Cervical Cancer
Clinical trial NCT05879796 · UNKNOWN
Trial details
- NCT number
- NCT05879796
- Sponsor
- Peking University Third Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-05-16
- Primary completion
- 2024-05-16
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.